Adlego Biomedical assist pharmaceutical companies with all aspects of their non-clinical drug development. They help customers in their endeavors to find cures for diseases for which there are no effective treatments today and those who are working to improve the effectiveness of discovered drugs.
Adlego Biomedical’s main focus is to establish long-term collaboration with drug developing companies that are early in their development of new candidate drugs. They are operating in state-of-the-art facilities, which have the flexibility needed to take on short-term basic DMPK studies as well as regulatory GLP toxicology studies. In addition, they work with disease models for cancer and pathogenic microbes at bio safety level 3, if needed.